Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma.
NCT04284631 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2020-04-01
Summary
To assess alterations of EGFR\& Her2neu expression in primary ovarian high grade serous carcinoma and its correlation with other clinicopathological parameters
Conditions
Sponsors & Collaborators
-
Port Said University hospital
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-01
- Primary Completion
- 2014-12-30
- Completion
- 2019-12-30
More Related Trials
-
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
NCT02668913 ·Status: COMPLETED ·Phase: NA
-
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
NCT06238284 ·Status: UNKNOWN
-
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
NCT02538562 ·Status: COMPLETED
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
NCT00858078 ·Status: COMPLETED
-
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
NCT00155896 ·Status: UNKNOWN
-
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
NCT01258881 ·Status: UNKNOWN
-
The Role of POLE Mutation in High Risk Endometrial Cancer.
NCT07114653 ·Status: RECRUITING
-
Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
NCT06853730 ·Status: COMPLETED
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
NCT05693987 ·Status: UNKNOWN
-
Characterization of Ovarian Cancer Stem Cell
NCT01367353 ·Status: UNKNOWN ·Phase: NA
-
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients
NCT04222465 ·Status: COMPLETED
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
NCT05693974 ·Status: UNKNOWN
-
Proteogenomic Signatures Analysis In Ovarian Cancer
NCT05953883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
NCT06759714 ·Status: RECRUITING
-
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
NCT06274541 ·Status: COMPLETED
-
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
NCT05168631 ·Status: ACTIVE_NOT_RECRUITING
-
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
NCT04651920 ·Status: COMPLETED
-
Newer Therapeutic Targets in Head and Neck Cancers
NCT05382585 ·Status: RECRUITING
-
Analysis of miRNA Expression in Endometrial Cancer
NCT04845425 ·Status: UNKNOWN
-
Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression
NCT06760923 ·Status: RECRUITING
-
Predictors of Node Positivity in Endometrial Cancer
NCT05793333 ·Status: RECRUITING
-
Testing BRCA 1/2 Mutation Using Next Generation Sequencing
NCT02151747 ·Status: COMPLETED
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING